Detalles de la búsqueda
1.
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).
Cancers (Basel)
; 15(20)2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894366
Resultados
1 -
1
de 1
1
Próxima >
>>